South Carolina
Excellence Initiative
for Eliminating Disparities
In Healthcare
 
HOME INTRODUCTION PROJECTS PILOT PROJECTS CORES NEWS ROOM INFO CENTER LINKS
 INTRODUCTION
  Program Overview
  Black Population in 2000
  Black Poverty in 1999
  Annual Reports
  Other Exceed Centers
 PROJECTS
  Treating Hypertension
  Treating HIV/AIDS
  End-Of-Life Care
  Refilling Prescriptions
 PILOT PROJECTS
  Group Visits for Diabetes
  Diabetes & Depression
  Adherence to MST
  Pain Management
 CORES
  Administrative Core
  Biostatistics Core
  Investigator Dev. Core
 PUBLIC NEWS ROOM
  Seminar Announcement
  News
  Fundings & Resources
  Conferences and Call for Paper
  Other Information
 STAFF INFO CENTER
  Secure Login
  MUSC Boilerplate
  GCRC at MUSC
  Staff Directory
  ORS Request Procedure
  Healthcare Privacy Rule (PDF)
 MEDTEP APPENDIX
 LINKS
EXCEED Project 2
 
Economic Access to Antiretroviral (ARV) Prescription Drugs and Adherence to ARV Guidelines for African American Medicaid Enrollees with HIV-Disease in South Carolina
 
South Carolina ranked fifth in the U.S. with regard to rate of new cases of HIV infection reported in 1998. Of these 76 percent were black, and one quarter were infected through heterosexual contact. The proportion of new HIV cases in South Carolina who are women of child-bearing age increased from 23 percent in 1990 to 33 percent in 1997; of these more than 85 percent are black.

The extent of under- treatment of black Medicaid HIV patients in South Carolina is not known because Medicaid does not have a separate mechanism for managing drug therapy for its HIV-infected clients. Even though Medicaid HIV patients are entitled to receive the recommended drugs, in fact this does not always happen. South Carolina is largely a rural poor state where many black HIV patients receive their care from primary care providers who are not familiar with the latest ARV guidelines. A disproportionately high proportion of the 30 percent of SC's population who are black are dependent on Medicaid for access to medical care and prescription drugs.

This project will identify the magnitude of this problem and its health and economic consequences, and begin to develop solutions. This study will:
  1. use the Office of Research and Statistics (ORS) to identify black Medicaid patients with AIDS/HIV (PWAs) who have no bills for ARV drugs, or whose prescription drug bills are not consistent with the utilization patterns expected for individuals adhering to ARV guidelines;
  2. use the ORS to group patients with no ARV bills by primary care provider ID number, and patients with ARV bills by pharmacy ID number and share and provide blinded data to the PI;
  3. estimate quality of life and budget impacts of potential improvements of adherence to ARV guidelines for SC Medicaid patients;
  4. collect information and make evidence summaries of approaches from SC and other states which have proven successful in increasing HAART drug uptake rates and/or AVR adherence for black PWAs in rural/poverty areas; and
  5. provide blinded data from Step 2,along with data from Steps 3 and 4 to Medicaid staff. We will provide analytical and consultative support to enable Medicaid officials, case managers, medical leaders and others from the eleven regional AIDS Care Consortia to develop culturally-sensitive plans for optimizing use and adherence to ARV for black Medicaid PWAs in SC; and
  6. we will monitor Medicaid billing data for two years and provide data based summaries/feedback to Medicaid, and community leaders to continuously improve the system for facilitating access and adherence to ARV guidelines for SC black Medicaid PWAs.

Powerpoint Presentation
Service Center Medical University of South carolina         Department of Biostatistics, Bioinformatics, and Epidemiology
Please send comments, suggestions or questions to: webmaster